Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study

Area of Science:

• Neurology
• Neuroimmunology
• Clinical Neuroscience

Background:

• Multiple sclerosis (MS) often initiates with a clinically isolated syndrome (CIS), a single neurological attack.
• Predicting conversion from CIS to MS is crucial for timely therapeutic intervention.
• Existing studies show variable conversion rates, highlighting the need for precise predictive factors.

Purpose of the Study:

• To identify independent predictors for the conversion of CIS to MS.
• To evaluate demographic, clinical, MRI, CSF, and electrophysiological parameters.
• To utilize the 2010 McDonald MS diagnostic criteria for assessing conversion.

Main Methods:

• Prospective longitudinal study of 64 CIS patients over at least 24 months.
• Assessment of conversion to MS based on clinical relapse or new MRI lesions.
• Analysis of baseline MRI T2 lesions, oligoclonal bands (OCB), and multimodal evoked potentials (EP).

Main Results:

• 70.3% of CIS patients converted to MS within the follow-up period.
• Predictors for conversion included: >10 baseline MRI T2 lesions (OR 3.107), OCB positivity (OR 5.958), and subclinical EP abnormality (OR 14.400).
• Multivariate models confirmed these as independent predictors with 84% sensitivity and 63% specificity.

Conclusions:

• Baseline MRI T2 lesion load and OCB positivity are established predictors for CIS to MS conversion.
• Subclinical abnormalities in multimodal evoked potentials (EP) demonstrate significant predictive value.
• These findings enhance the ability to identify patients at high risk of MS progression.